tool
avail
infecti
diseas
diagnost
human
ident
test
benefit
major
technolog
advanc
among
signific
advanc
invent
polymeras
chain
reaction
pcr
saiki
et
al
made
possibl
easili
quickli
amplifi
specif
nucleic
acid
sequenc
microscop
quantiti
dna
collect
patient
specimen
recov
item
evid
crimin
case
regardless
type
specimen
analyz
howev
first
step
pcrbase
molecular
genet
assay
prepar
nucleic
acid
extract
origin
perform
manual
typic
boil
chemic
lysi
use
noxiou
organ
solvent
like
phenolechloroform
ethanol
precipit
wide
varieti
commerci
avail
instrument
sinc
develop
autom
process
fujii
et
al
autom
cell
lysi
achiev
use
deterg
chaotrop
salt
heat
mechan
disrupt
simpl
pressur
autom
nucleic
acid
extractionpurif
typic
employ
variant
solid
phase
extract
wherebi
nucleic
acid
select
revers
bound
solid
substrat
typic
silica
therebi
allow
protein
unwant
cellular
compon
wash
away
pure
nucleic
acid
elut
appropri
buffer
downstream
applic
autom
platform
provid
faster
consist
result
manual
method
use
higher
densiti
specimen
process
format
also
greatli
increas
specimen
throughput
led
improv
economi
scale
second
step
pcr
amplif
process
sinc
perform
programm
thermal
cycler
mean
heat
block
temperaturecontrol
air
chamber
specimen
cycl
repeat
round
dna
denatur
targetspecif
primer
anneal
nascent
strand
extens
technic
advanc
focus
polymeras
function
eg
process
fidel
stabil
reduc
reaction
volum
improv
thermal
transit
reduc
total
amplif
run
time
third
step
detect
analysi
amplifi
product
pcr
size
conform
fraction
slabgel
capillari
electrophoresi
ce
long
default
technolog
avail
precast
gel
capillari
array
connect
gel
pump
higherdens
format
autom
sampl
load
help
increas
specimen
throughput
howev
process
remain
somewhat
labori
timeconsum
advanc
altern
technolog
pcr
amplicon
detect
analysi
sought
circumv
limit
electrophoresisbas
approach
detect
target
amplicon
amplif
process
approach
employ
intercal
compound
minorgroov
bind
dye
wide
varieti
hybrid
probe
eg
molecular
beacon
scorpion
detect
quantifi
bind
nascent
strand
dna
creat
cycl
pcr
process
anoth
approach
avoid
need
postamplif
fraction
gel
electrophoresi
melt
curv
analysi
postamplif
assay
perform
without
need
remov
aliquot
amplifi
dna
pcr
tube
examin
helixdissoci
profil
ie
melt
curv
nascent
doublestrand
dna
subject
increas
temperatur
melt
curv
amplicon
function
sequencespecif
nearestneighbor
thermodynam
interact
result
melt
curv
serv
signatur
presenc
amplifi
target
sequenc
see
chapter
comprehens
discuss
underli
principl
realtim
pcr
highresolut
melt
curv
analysi
respect
applic
molecular
diagnost
final
step
pcrbase
molecular
assay
data
interpret
wherebi
fragment
detect
gel
electrophoresi
ce
realtim
pcr
amplif
curv
postamplif
melt
curv
interpret
narrowli
tailor
welloptim
pcr
assay
clearli
defin
expect
outcom
interpret
rel
simpl
rapid
process
exampl
pcrbase
diagnost
test
methicillinresist
staphylococcu
aureu
clostridium
difficil
tuberculosi
tb
rel
simpl
lowmultiplex
assay
yield
welldefin
clinic
answer
sharp
contrast
pcrbase
assay
human
ident
test
may
use
kinship
analysi
forens
dna
crime
laboratori
use
short
tandem
repeat
str
target
genet
marker
highli
variabl
natur
forens
evid
regard
sampl
integr
dna
quantiti
contributor
complex
make
data
interpret
especi
timeand
laborintens
process
requir
manual
review
skill
laboratori
analyst
effort
streamlin
process
focus
develop
power
expert
system
comput
softwar
guid
userdefin
rule
goal
abl
consist
analyz
given
set
data
skill
human
hane
gill
expert
system
replac
human
rather
autom
tediou
often
timeconsum
aspect
data
analysi
provid
analyst
qualiti
score
analyz
data
explan
reason
program
use
support
specif
analyt
outcom
see
chapter
comprehens
discuss
use
dna
test
human
ident
applic
even
advanc
made
laboratori
autom
tradit
diagnost
assay
workflow
remain
larg
segment
specimen
reagent
usual
manual
load
unload
differ
instrument
transport
among
differ
physic
locat
within
laboratori
minimum
includ
dedic
prepcr
lowtempl
extract
purif
postpcr
hightempl
amplif
postamplif
analysi
area
laboratori
purpos
segreg
work
area
minim
chanc
gener
erron
assay
result
inadvert
introduct
previous
amplifi
nucleic
acid
preamplif
nucleic
acid
extract
preamplif
process
medic
diagnost
context
forens
context
undetect
contamin
one
specimen
pcramplifi
product
differ
specimen
could
catastroph
consequ
wide
recogn
even
stringent
standard
oper
procedur
utmost
caution
imposs
complet
elimin
risk
crosscontamin
perform
pcrbase
assay
use
segment
workflow
even
individu
segment
autom
reason
laboratori
typic
employ
multipl
layer
control
qualiti
check
design
prevent
crosscontamin
also
ensur
detect
rare
instanc
occur
subsequ
root
caus
analysi
correct
action
report
gener
effort
perpetu
improv
overal
process
remark
shift
laborintens
assay
segment
workflow
fulli
autom
integr
instrument
tradit
dnabas
assay
requir
extens
handson
time
isol
nucleic
acid
test
specimen
amplifi
diagnost
inform
amplicon
convert
raw
electrophoret
fraction
highresolut
melt
curv
hybrid
data
diagnost
meaning
result
new
gener
easi
use
fulli
autom
assay
greatli
streamlin
entir
process
various
describ
sampletoansw
samplein
answerout
system
medic
diagnost
sampleto
profil
system
human
ident
test
instrument
integr
fulli
autom
nucleic
acid
extract
amplif
detect
data
interpret
report
singl
devic
park
et
al
sackmann
et
al
buchan
ledebo
miniatur
instrument
reduct
reaction
volum
without
loss
data
output
qualiti
hallmark
modern
molecular
biolog
advanc
core
sampletoansw
assay
necessari
chemic
reagent
test
specimen
form
intern
process
control
prepackag
either
liquid
dri
state
dispos
assay
cassett
blister
pack
typic
specimen
process
along
dedic
pathway
physic
isol
specimen
entir
analyt
process
elimin
opportun
potenti
crosscontamin
exist
tradit
segment
workflow
result
laboratori
abl
bypass
mani
burdensom
expens
procedur
infrastructur
aspect
contamin
control
system
lightweight
benchtop
instrument
small
footprint
make
portabl
thu
well
suit
near
pointofcar
diagnost
even
lower
resourc
environ
similarli
sampletoprofil
human
ident
test
system
compact
enough
use
polic
depart
book
station
mobil
crime
scene
van
airport
secur
area
fieldforward
militari
site
instrument
assay
cassett
run
minim
handson
oper
staff
less
technic
train
typic
need
tradit
diagnost
lab
technologist
forens
analyst
elimin
segment
workflow
assay
specimen
parallel
system
typic
much
faster
turnaround
time
convent
assay
medic
diagnost
arena
sensit
specif
sampletoansw
assay
system
compar
convent
method
identif
caus
organ
respons
given
patholog
often
time
presenc
organ
specif
gene
associ
antimicrobi
resist
trait
andor
virul
factor
similarli
accuraci
sampletoprofil
instrument
human
ident
test
compar
convent
method
analysi
buccal
swab
good
qualiti
refer
type
sampl
number
sampletoansw
sampletoprofil
system
commerci
avail
tabl
includ
filmarray
biofir
genexpert
cepheid
liat
pcr
system
coba
roch
simplexa
integr
cycler
focu
diagnost
verigen
system
nanosphereluminex
rapidhit
dna
profil
integenx
dnascan
rapid
dna
analysi
system
netbiogener
electr
ge
healthcar
certainli
exhaust
list
exampl
encompass
rang
gener
oper
principl
underli
system
specif
detail
regard
individu
assay
chemistri
run
system
provid
chapter
context
specif
clinic
ident
test
applic
filmarray
system
fig
provid
gener
illustr
fulli
integr
pcrbase
sampletoansw
system
filmarray
system
combin
autom
vitro
diagnost
instrument
base
unit
assayspecif
pouch
detect
multipl
nucleic
acid
target
clinic
specimen
xu
et
al
assay
pouch
dispos
selfcontain
close
system
contain
reagent
requir
extract
amplifi
detect
specif
nucleic
acid
target
may
present
clinic
specimen
poritz
et
al
reservoir
rigid
plastic
compon
fitment
pouch
contain
lyophil
reagent
flexibl
plastic
film
portion
pouch
divid
seri
blister
packlik
compart
seri
chemic
process
execut
interact
pouch
actuat
sensor
base
unit
includ
cell
lysi
nucleic
acid
extract
purif
test
specimen
firststag
multiplex
pcr
secondstag
singleplex
pcr
melt
analysi
take
place
multiwel
array
run
assay
technician
use
syring
load
hydrat
solut
pouch
rehydr
lyophil
reagent
prepackag
pouch
fitment
patient
specimen
mix
sampl
buffer
inactiv
rnase
specimen
later
facilit
bind
nucleic
acid
magnet
bead
nucleic
acid
isol
sampl
load
syring
use
transfer
specimensampl
buffer
mixtur
pouch
pouch
load
base
unit
technician
initi
specimen
run
seri
plunger
pneumat
actuat
hard
seal
work
togeth
mix
liquid
reagent
move
blister
pouch
grover
et
al
filmarray
base
unit
automat
perform
function
base
run
protocol
select
specif
pouch
assay
chemistri
specimen
type
instrument
oper
softwar
nucleic
acid
isol
occur
first
three
blister
compart
pouch
first
step
process
specimen
lyse
outer
membran
target
microb
may
patient
specimen
done
use
devic
call
beadbeat
sensor
base
unit
monitor
speed
oper
beadbeat
abort
run
beadbeat
work
properli
follow
beadbeat
nucleic
acid
contain
sampl
captur
wash
elut
magnet
bead
technolog
retract
magnet
use
captur
releas
magnet
bead
wash
step
requir
min
complet
next
step
process
revers
transcript
rt
firststag
multiplex
pcr
amplif
rt
figur
photograph
imag
left
schemat
diagram
right
show
salient
featur
filmarray
assay
system
consist
hard
plastic
fitment
contain
reagent
reservoir
flexibl
plastic
film
pouch
consist
seri
reaction
chamber
transfer
channel
sampl
introduc
sampl
inject
port
pouch
insert
filmarray
instrument
base
unit
shown
process
color
liquid
shown
photograph
facilit
visual
actual
filmarray
pouch
contain
color
liquid
pcr
polymeras
chain
reaction
imag
adapt
filmarray
oper
manual
ce
ivd
step
necessari
convert
rna
cdna
prior
firststag
multiplex
pcr
amplif
assay
target
pathogen
identif
rna
genom
eg
coronaviru
orthomyxoviru
picornaviru
noroviru
sapoviru
purifi
nucleic
acid
extract
mix
preheat
master
mix
initi
rt
step
subsequ
thermocycl
multiplex
pcr
amplifi
target
identifi
pouch
well
process
control
amplicon
peltier
devic
drive
thermocycl
rt
reaction
requir
firststag
pcr
reaction
purpos
firststag
pcr
enrich
target
nucleic
acid
present
patient
specimen
amplifi
product
firststag
pcr
dilut
combin
fresh
pcr
reagent
contain
satur
fluoresc
intercal
dna
dye
lcgreen
plu
solut
distribut
secondstag
pcr
array
individu
well
array
contain
primer
differ
assay
triplic
target
specif
nucleic
acid
sequenc
pathogen
target
pouch
assay
well
primer
intern
posit
control
anneal
site
secondstag
pcr
primer
locat
within
sequenc
amplifi
product
gener
firststag
multiplex
pcr
ie
nest
pcr
serv
enhanc
sensit
specif
assay
complet
last
cycl
secondstag
pcr
dna
melt
curv
analysi
perform
identifi
posit
neg
pcr
reaction
use
determin
target
microb
present
patient
specimen
secondstag
pcr
process
lcgreen
plu
dye
incorpor
copi
dna
made
pcr
cycl
bound
doublestrand
dna
dye
fluoresc
temperatur
increas
copi
doublestrand
dna
melt
dye
releas
correspond
drop
fluoresc
dna
melt
curv
gener
slowli
increas
temperatur
pcr
array
done
fluoresc
emit
dnabound
dye
well
array
imag
camera
record
second
peltier
devic
control
thermocycl
secondstag
pcr
dna
melt
analysi
firststag
pcr
thermocycl
profil
control
accord
program
run
protocol
specif
reagent
pouch
assay
perform
secondstag
pcr
melt
analysi
take
place
array
locat
final
pouch
blister
melt
profil
target
amplicon
microb
assay
known
pcr
product
specif
microb
readili
identifi
two
intern
posit
control
incorpor
assay
first
rna
process
control
rpc
rpc
employ
lyophil
yeast
schizosaccharomyc
pomb
prepackag
assay
pouch
rehydr
patient
specimen
load
yeast
carri
stage
test
process
includ
lysi
nucleic
acid
purif
firststag
pcr
dilut
secondstag
pcr
dna
melt
curv
analysi
rna
transcript
present
rpc
target
amplif
posit
control
result
indic
step
carri
assay
pouch
success
secondstag
pcr
control
also
includ
control
detect
dna
target
dri
well
array
along
correspond
amplif
primer
posit
result
indic
success
secondstag
pcr
filmarray
base
unit
softwar
automat
analyz
melt
curv
data
replic
well
secondstag
pcr
reaction
control
test
sampl
automat
gener
test
report
end
run
indic
target
microb
detect
either
control
fail
result
report
invalid
base
independ
workflow
analysi
studi
butt
et
al
entir
process
specimentoansw
take
h
complet
min
actual
handson
time
commerci
avail
platform
take
similar
approach
integr
specimen
process
singleus
cartridg
system
though
specif
nucleic
acid
extract
target
amplif
detect
vari
genexpert
system
exampl
combin
base
unit
analyz
small
dispos
cartridg
modul
barcod
preload
necessari
reagent
particular
assay
lawn
et
al
tortoli
et
al
patient
specimen
place
cartridg
load
base
unit
read
cartridg
barcod
initi
assayspecif
protocol
nucleic
acid
extract
take
place
process
chamber
contain
reagent
filter
captur
technolog
necessari
extract
purifi
amplifi
target
nucleic
acid
nucleic
acid
extract
employ
combin
chemic
ultrason
lysi
follow
rtpcr
fluoresc
monitor
multipl
channel
target
control
signal
integr
valv
use
facilit
fluid
transfer
chamber
chamber
thin
pcr
chamber
wall
enabl
rapid
thermal
cycl
system
softwar
interpret
detect
signal
gener
report
result
total
run
time
h
system
base
unit
avail
configur
equip
robot
load
system
minim
handson
time
even
higher
volum
laboratori
modul
within
base
unit
oper
individu
mani
differ
assay
eg
mycobacterium
tuberculosi
methicillinresist
aureu
c
difficil
necessari
run
technician
time
therefor
system
flexibl
scalabl
need
specif
laboratori
key
advantag
rel
filmarray
system
system
process
one
assay
pouch
time
filmarray
howev
abl
screen
greater
number
target
pathogen
per
pouch
liat
stand
lab
tube
system
anoth
realtim
pcrbase
assay
system
util
small
dispos
linear
tube
binnick
et
al
chen
et
al
tube
contain
reagent
necessari
perform
assay
reagent
arrang
seri
blister
pack
compart
use
transfer
pipett
patient
specimen
introduc
top
assay
tube
assay
tube
cap
insert
analyz
base
unit
integr
nucleic
acid
test
process
includ
reagent
prepar
target
enrich
inhibitor
remov
nucleic
acid
extract
amplif
realtim
detect
specimen
sampl
handl
control
use
multipl
sampl
process
modul
contain
within
base
unit
specimen
process
modul
consist
two
assembl
first
move
side
assembl
compris
multipl
sampl
process
plunger
clamp
second
fixedsid
assembl
plunger
clamp
select
compress
liat
assay
tube
segment
fixedsid
assembl
select
releas
reagent
individu
tube
blister
compart
move
sampl
one
compart
anoth
nucleic
acid
extract
process
base
lysi
chaotrop
salt
follow
solid
phase
magnet
particlebas
nucleic
acid
purif
detect
amplifi
target
employ
fluorogen
label
hydrolysi
probe
eg
taqman
probe
integr
system
intern
posit
control
use
confirm
instrument
perform
result
determin
intern
posit
control
ipc
compris
encapsul
rna
prepack
liat
tube
base
analyz
unit
control
reaction
condit
thermal
cycl
temperatur
accord
specif
assay
program
data
analysi
employ
predefin
decis
algorithm
gener
report
assay
result
like
filmarray
system
liat
system
process
one
specimen
time
result
typic
gener
min
simplexa
molecular
assay
system
use
diskbas
centrifug
microfluid
realtim
pcr
assay
design
run
integr
cycler
strohmeier
et
al
miao
et
al
user
given
choic
two
oper
mode
first
mode
thermocycleonli
disk
use
allow
standard
realtim
pcr
assay
requir
patient
specimen
extract
separ
disk
load
purifi
dna
radial
inwardori
inlet
well
connect
one
amplif
well
posit
outer
rim
disk
contact
heat
employ
thermocycl
realtim
detect
record
data
four
fluoresc
channel
second
mode
oper
direct
amplif
disk
use
provid
true
sampletoansw
function
second
mode
space
direct
amplif
disk
occupi
mostli
extract
microfluid
therefor
eight
fulli
integr
sampl
process
reaction
run
time
use
disk
requir
littl
handson
time
asid
pipet
ml
reaction
mix
onto
disk
prior
process
patient
sampl
sampl
assay
pipet
well
near
center
disk
technician
enter
assay
run
paramet
initi
run
disk
spin
centrifug
forc
move
patient
specimen
reaction
reagent
reaction
chamber
direct
amplif
disk
make
use
direct
amplif
chemistri
perform
nucleic
acid
extract
amplif
one
protocol
infrar
energi
highveloc
fan
use
heat
cool
realtim
pcr
reaction
chamber
disk
rapid
temperatur
transit
effici
heat
transfer
translat
shorter
cycl
time
littl
cycl
thermocycleonli
disk
four
fluoresc
channel
avail
target
detect
system
softwar
collect
analyz
result
simplexa
system
provid
result
patient
swab
h
similar
specimen
process
approach
quit
differ
detect
technolog
employ
verigen
system
use
selfcontain
test
cartridg
conjunct
two
separ
instrument
modul
cartridg
processor
cartridg
reader
dispos
test
cartridg
design
multiplex
analysi
singl
patient
specimen
featur
microfluid
cassett
contain
hybrid
reagent
need
assay
captur
wast
materi
gener
process
also
contain
glass
slide
serv
solid
support
microarray
target
nucleic
acid
captur
detect
cartridg
processor
unit
manag
autom
nucleic
acid
extract
purif
amplif
requir
hybrid
process
test
cartridg
genom
dna
extract
shear
sonic
base
pair
fragment
fragment
size
easili
manipul
readili
hybrid
molecul
fragment
genom
dna
allow
hybrid
microarray
captur
probe
attach
glass
slide
assay
cartridg
oligonucleotid
probe
conjug
gold
nanoparticl
introduc
allow
bind
complementari
genom
dna
fragment
present
microarray
unbound
oligonucleotidegold
nanoparticl
probe
wash
away
element
silver
deposit
onto
gold
nanoparticl
probe
bound
remain
serv
ampli
signal
optic
detect
light
scatter
derivit
gold
nanoparticl
giljohann
et
al
detect
sensit
achiev
use
gold
nanoparticl
exce
fluoresc
dyebas
detect
method
employ
sampletoansw
system
much
nucleic
acid
amplif
option
verigen
system
alway
necessari
omit
assay
final
cartridg
reader
imag
microarray
analyz
result
process
cartridg
order
gener
report
base
independ
evalu
system
butt
et
al
result
typic
gener
approxim
h
make
system
competit
sampletoansw
system
total
amount
handson
time
min
longer
handson
time
attribut
need
thaw
frozen
reagent
move
cartridg
analyz
reader
develop
system
human
ident
test
integr
requir
process
way
even
challeng
goal
develop
mani
sampletoansw
medic
diagnost
assay
reason
medic
diagnost
assay
typic
need
detect
presenc
amplifi
dna
sequenc
target
microorgan
human
ident
test
kinship
analysi
forens
purpos
howev
present
need
identifi
specif
length
variant
str
genet
marker
target
analysi
necessit
expans
basic
integr
pcr
system
includ
sizefraction
process
convent
forens
laboratori
perform
use
ce
incorpor
fulli
integr
system
proven
challeng
signific
progress
made
success
achiev
interfac
nucleic
acid
extract
amplif
cartridg
standard
ce
modul
microfluid
ce
sever
parallel
effort
result
commerci
avail
fulli
integr
devic
integr
workflow
requir
sampletoprofil
human
ident
test
rapidhit
system
fig
provid
illustr
complex
workflow
holland
wendt
hennessi
et
al
rapidhit
fulli
integr
sampletoprofil
dna
identif
system
use
four
dispos
cartridg
conjunct
instrument
base
unit
sampl
control
cartridg
integr
nucleic
acid
extract
pcr
amplif
process
anod
cartridg
contain
linear
sampl
swab
place
inlet
port
lysi
solut
pump
lysi
solut
reservoir
swab
suspend
cell
swab
pump
magnet
bead
chamber
cell
lyse
dna
immobil
magnet
bead
ethanol
pump
sequenti
ethanol
reservoir
wash
immobil
dna
bead
chamber
use
ethanol
wash
deposit
wast
receptacl
bead
purifi
dna
transfer
polymeras
chain
reaction
pcr
chamber
mix
pcr
premix
pcr
amplif
amplicon
fraction
offcartridg
imag
adapt
integenx
polyacrylamid
capillari
electrophoresi
agent
dynam
coat
wall
capillari
reduc
electroosmot
flow
electrophoresi
anod
electrod
electrophoresi
buffer
cartridg
serv
reservoir
ce
cathod
buffer
water
process
also
receptacl
wast
materi
sampl
control
cartridg
inject
mold
produc
integr
fluidic
devic
consist
seri
chamber
fluid
channel
interfac
pneumat
driven
valv
pump
extern
actuat
transport
sampl
mix
fluidic
stream
grover
et
al
sampl
cartridg
four
sampl
port
dedic
fluidic
pathway
process
four
swab
cellular
materi
typic
buccal
swab
control
cartridg
process
one
sampl
port
dedic
fluidic
pathway
remain
three
fluidic
pathway
reserv
intern
posit
control
known
dna
standard
neg
control
typic
sampl
monitor
contamin
reagent
andor
fluidic
path
extran
human
dna
allel
ladder
prepackag
sizestandard
chamber
flow
path
serv
standard
allel
determin
data
analysi
rapidhit
base
unit
cartridg
insert
process
four
primari
subsystem
one
sampl
prepar
fraction
detect
controlanalysi
sampl
prepar
subsystem
manag
oper
sampl
control
cartridg
use
pneumat
move
liquid
one
chamber
next
lysi
employ
combin
heat
chaotrop
guanidinium
salt
releas
dna
captur
purifi
use
solid
phase
extract
magnet
bead
bead
bound
dna
transfer
reaction
chamber
immobil
fix
magnet
multiplex
pcr
master
mix
primer
either
str
loci
powerplex
fast
globalfil
express
chemistri
respect
ad
reaction
chamber
amplifi
use
peltier
thermocycl
amplifi
product
move
sizestandard
chamber
mix
intern
lane
size
standard
pump
separ
subsystem
receiv
separ
subsystem
separ
modul
hous
base
unit
linear
polyacrylamid
anod
cartridg
use
fill
eight
separ
capillari
amplifi
sampl
heat
denatur
electrokinet
inject
size
fraction
ce
use
buffer
buffer
cartridg
run
capillari
automat
clean
prepar
next
run
detect
subsystem
use
solidst
laser
excit
fluoresc
tag
str
product
detect
chargecoupl
devic
camera
pass
capillari
detect
window
data
fluoresc
intens
ce
mobil
collect
store
controlanalysi
subsystem
hous
embed
comput
control
instrument
oper
subsystem
automat
process
raw
data
nois
filter
baselin
subtract
spectral
deconvolut
primer
peak
remov
local
copi
genemark
hid
human
ident
softwar
identifi
specif
genotyp
str
loci
order
gener
report
dna
profil
sampl
total
process
time
swab
dna
profil
approxim
min
dnascan
fig
repres
altern
approach
gener
strbase
human
dna
profil
employ
singleus
dispos
microfluid
cassett
dna
profil
process
includ
size
fraction
pcr
amplicon
togeth
instrument
base
unit
manag
workflow
function
core
system
injectionmold
biochipset
cassett
bcsc
construct
four
major
compon
smart
cartridg
gel
smart
cartridg
integr
biochip
separ
detect
biochip
bcsc
preload
necessari
reagent
sampl
process
liquid
reagent
store
reservoir
aluminum
foil
seal
bond
end
pneumat
pressur
use
burst
seal
therebi
releas
content
reservoir
lyophil
reagent
eg
pcr
master
mix
intern
lane
size
standard
allel
ladder
also
preload
within
chamber
bcsc
reconstitut
liquid
phase
reaction
product
move
bcsc
smart
cartridg
process
five
buccal
swab
time
system
nucleic
acid
purif
method
employ
chaotrop
guanidinium
salt
lysi
follow
guanidiniummedi
bind
dna
solid
phase
silica
surfac
dna
extract
pcr
amplifi
pcr
master
mix
contain
primer
amplifi
str
loci
ie
powerplex
chemistri
altern
multiplex
pcr
master
mix
also
develop
test
gel
smart
cartridg
contain
linear
polyacrylamid
siev
matrix
electrophoresi
buffer
use
microfluid
size
fraction
detect
signific
differ
rapidhit
system
rather
tradit
capillari
separ
detect
biochip
perform
electrophoresi
six
independ
microfluid
channel
cm
long
crosssect
dimens
mm
mm
order
minim
potenti
interfer
plastic
autofluoresc
entir
bcsc
fabric
cyclic
olefin
polym
produc
less
autofluoresc
glass
fluoresc
label
amplifi
str
fragment
excit
solid
state
laser
optic
subsystem
base
unit
laser
light
excit
transmit
detect
window
separ
detect
biochip
result
fluoresc
detect
seri
photomultipli
tube
detector
integr
biochip
compon
contain
microfluid
channel
chamber
repres
core
bcsc
interfac
smart
cartridg
facilit
nucleic
acid
purif
provid
mean
liquid
transfer
chamber
chamber
integr
biochip
also
accept
purifi
dna
smart
cartridg
prepar
process
perform
pcr
interfac
separ
detect
biochip
provid
transfer
electrophoresisreadi
sampl
separ
channel
upon
complet
sampl
run
raw
electrophoret
data
process
achiev
baselin
subtract
spectral
deconvolut
identifi
signal
peak
produc
interpret
electropherogram
final
expert
system
algorithm
use
autom
allel
call
softwar
interpret
process
data
determin
genotyp
amplifi
loci
collect
form
dna
profil
analyz
sampl
similar
rapidhit
system
dnascan
system
abl
gener
dna
profil
fulli
autom
fulli
integr
process
buccal
swab
min
respiratori
system
one
frequent
site
colon
infecti
agent
respiratori
infect
also
import
driver
patient
hospit
sever
sampletoansw
assay
avail
detect
wide
varieti
respiratori
pathogen
pcr
influenza
viru
detect
mani
advantag
convent
diagnost
techniqu
exampl
detect
influenza
cultur
take
sever
day
antigendetectionbas
test
simpl
fast
suffer
low
sensit
requir
somewhat
tediou
examin
cell
fluoresc
microscopi
contrast
nucleic
acid
test
fast
sensit
specif
well
suit
sampletoansw
platform
filmarray
respiratori
panel
rp
first
gain
us
food
drug
administr
fda
approv
current
iter
filmarray
rp
target
detect
microb
includ
numer
viral
strain
speci
bacteria
tabl
detect
sensit
vari
organ
differ
version
assay
doern
et
al
overal
sensit
report
independ
research
vari
slightli
report
manufactur
tabl
gener
fall
within
rang
target
pathogen
except
influenza
b
adenoviru
sensit
respect
couturi
et
al
assay
intend
use
nasopharyng
swab
good
sensit
also
report
type
specimen
includ
nose
throat
swab
sputum
specimen
collect
lower
respiratori
tract
branch
et
al
ruggiero
et
al
cepheid
xpert
flu
assay
detect
discrimin
among
influenza
influenza
influenza
b
use
either
nasopharyng
swab
nasal
aspir
overal
sensit
approxim
though
research
seen
somewhat
lower
sensit
influenza
b
duga
et
al
xpert
flursv
xc
differ
xpert
assay
cartridg
differenti
influenza
influenza
b
respiratori
syncyti
viru
rsv
studi
indic
compar
molecular
assay
sensit
xpert
flursv
xc
assay
virus
rang
low
influenza
popowitch
miller
salez
et
al
salez
et
al
sampletoansw
assay
approv
respiratori
pathogen
includ
simplexa
flu
ab
rsv
assay
verigen
respiratori
viral
plu
panel
liat
influenza
b
assay
panel
compar
inhous
rtpcr
sensit
simplexa
ab
rsv
assay
influenza
b
rsv
respect
woodberri
et
al
report
sensit
specif
verigen
greater
cho
et
al
boku
et
al
compar
simplexa
flu
ab
rsv
assay
liat
influenza
b
assay
panel
show
greater
sensit
influenza
influenza
b
binnick
et
al
mycobacterium
tuberculosi
pathogen
respons
tb
highli
contagi
airborn
diseas
rank
alongsid
hivaid
lead
caus
mortal
around
globe
drug
resist
becom
major
obstacl
effect
tb
treatment
prevent
spread
tb
fuel
improp
patient
treatment
poor
manag
drug
prescript
drug
qualiti
airborn
transmiss
bacteria
public
place
strategi
control
spread
tb
includ
drugresist
tb
reli
upon
slow
laborintens
diagnost
method
acidfast
bacilli
afb
smear
test
lawn
nicol
although
use
tb
detect
centuri
low
specif
sensit
cdc
accordingli
develop
faster
accur
diagnost
test
tuberculosi
top
prioriti
medic
commun
sampletoresult
molecular
test
tb
would
obviou
advantag
convent
smear
cultur
test
xpert
mtbrif
assay
detect
tb
resist
rifampin
sputum
specimen
target
tbspecif
sequenc
mutat
within
rpob
gene
confer
resist
rifampin
often
earli
marker
multidrugresist
tb
also
detect
assay
helb
et
al
base
result
multipl
evalu
studi
sensit
assay
vari
afb
smear
testposit
patient
specif
assay
rang
assay
abil
detect
rifampin
resist
exceed
sensit
specif
result
control
clinic
valid
studi
individu
suspect
tb
show
sensit
singl
direct
xpert
mtbrif
assay
smearneg
cultureposit
sampl
three
smearneg
sampl
test
specif
xpert
mtbrif
assay
sensit
specif
rifampin
resist
detect
respect
suggest
xpert
mtbrif
assay
without
limit
need
convent
drug
resist
test
elimin
still
necessari
detect
resist
antibiot
rifampin
neg
xpert
mtbrif
assay
result
exclud
diagnosi
tb
center
diseas
control
prevent
cdc
report
tb
case
unit
state
report
neg
cultur
result
may
also
neg
nucleic
acid
amplif
test
result
may
due
low
bacteri
load
presenc
inhibitori
substanc
sputum
specimen
cdc
infecti
diarrhea
impact
million
peopl
around
globe
year
associ
high
rate
morbid
mortal
especi
among
children
clinic
present
infecti
gastroenter
inform
term
specifi
etiolog
agent
diarrhea
primari
symptom
caus
wide
rang
caus
agent
challeng
select
appropri
pathogen
identif
assay
therefor
compound
fact
mani
pathogen
diagnost
test
avail
buss
et
al
may
partial
account
fact
etiolog
agent
infecti
diarrhea
identifi
patient
scallan
et
al
rapid
accur
detect
gastrointestin
gi
pathogen
vital
ensur
base
less
ten
posit
sampl
due
low
clinic
preval
prospect
studi
appropri
therapi
infect
control
strategi
liu
et
al
khare
et
al
tradit
bacterialvir
cultur
microscopi
search
ova
parasit
antigendetect
assay
method
choic
identif
gi
pathogen
recent
singleplex
realtim
pcr
assay
develop
identifi
specif
pathogen
method
often
timeconsum
laborintens
often
offer
littl
one
shot
dark
anoth
effort
identifi
caus
pathogen
physician
attract
situat
respect
patient
manag
infect
control
public
health
strategi
de
boer
et
al
abil
simultan
screen
presenc
wide
varieti
potenti
pathogen
multiplex
pcr
import
featur
mani
sampletoansw
assay
filmarray
gi
panel
verigen
enter
pathogen
ep
panel
two
assay
commerci
avail
fda
approv
filmarray
gi
panel
design
detect
target
virus
bacteria
parasit
verigen
ep
panel
design
detect
target
virus
bacteria
toxin
singl
assay
khare
et
al
filmarray
gi
panel
show
overal
greater
level
sensit
specif
studi
involv
case
gi
panel
report
sensitivityposit
predict
valu
target
plesiomona
shigelloid
salmonella
spp
yersinia
enterocolitica
enterotoxigen
escherichia
coli
shiga
toxinproduc
e
coli
e
coli
cryptosporidium
spp
cyclospora
cayetanensi
giardia
lamblia
astroviru
rotaviru
sapoviru
remain
target
sensitivityposit
predict
valu
anoth
advantag
gi
panel
abil
detect
multipl
pathogen
singl
assay
use
convent
method
identifi
one
pathogen
sampl
contrast
gi
panel
indic
presenc
mix
infect
specimen
buss
et
al
assess
prospect
contriv
specimen
conduct
smaller
verigen
ep
panel
show
sensit
salmonella
spp
campylobact
spp
shigella
spp
toxin
gene
toxin
gene
novak
sm
et
al
taken
togeth
studi
demonstr
integr
sampletoansw
diagnost
system
consist
outperform
tradit
culturebas
method
toxigen
c
difficil
quintessenti
hospitalacquir
pathogen
antibioticdriven
resist
multipl
antibiot
estim
preval
c
difficil
infect
may
high
hospit
patient
c
difficil
infect
endem
resid
longterm
care
facil
gener
less
ambulatori
adult
carriag
rate
higher
hospit
patient
unrel
condit
requir
longterm
treatment
antibiot
kill
intestin
bacteria
would
normal
keep
c
difficil
check
report
incid
c
difficil
coliti
among
hospit
inpati
rang
case
per
patient
day
rate
tend
increas
proport
durat
hospit
stay
dubberk
et
al
kyne
et
al
cohen
et
al
c
difficil
caus
spectrum
diseas
rang
antibioticassoci
diarrhea
pseudomembran
coliti
sewel
et
al
fast
accur
detect
c
difficil
infect
import
appropri
antibiot
treatment
proper
control
infect
outbreak
numer
wellestablish
method
avail
detect
c
difficil
stool
specimen
includ
stool
cultur
toxigen
cultur
antigen
detect
enzym
immunoassay
molecular
test
karen
john
stool
cultur
sensit
test
avail
labori
detect
toxin
product
lengthi
turnaround
time
day
tissu
cultur
cytotox
assay
requir
technic
expertis
slightli
faster
turnaround
time
day
still
less
specif
sensit
pcr
toxigen
culturebas
assay
antigendetect
assay
base
latex
agglutin
immunochromatographi
faster
produc
result
h
antigen
test
howev
nonspecif
pathogen
strain
enzym
immunoassay
design
detect
c
difficil
toxin
toxin
b
b
fast
econom
rel
insensit
sampletoansw
diagnost
assay
offer
superior
sensit
specif
fast
turnaround
time
fdaapprov
filmarray
gi
panel
discuss
previous
includ
singl
multiplex
assay
cdiff
identif
toxigen
c
difficil
assay
target
toxin
toxin
b
gene
tcda
tcdb
common
toxigen
strain
c
difficil
express
toxin
make
presenc
either
indic
pathogen
strain
empir
test
silico
sequenc
analys
indic
toxinotyp
detect
assay
includ
epidem
north
american
profil
hypervirul
strain
identifi
caus
hospit
outbreak
worldwid
chapin
et
al
although
detect
strain
specif
differenti
gi
assay
xpert
c
difficil
xpert
c
difficileepi
assay
approv
fda
perform
directli
stool
sampl
former
target
c
difficil
tcdb
shown
sensit
specif
novakweekley
et
al
latter
assay
differenti
hypervirul
strain
similarli
verigen
c
difficil
assay
abil
detect
toxinencod
tcda
tcdb
gene
identifi
strain
carrol
et
al
regardless
assay
use
rapid
sampletoansw
molecular
test
c
difficil
make
possibl
facilit
reduct
transmiss
outbreak
provid
costeffect
time
detect
pathogen
sewel
et
al
anoth
gi
pathogen
concern
noroviru
common
caus
acut
gastroenter
highli
contagi
via
fecalor
rout
transmiss
diseas
associ
crowd
live
environ
cruis
ship
school
dormitori
daycar
center
prison
accordingli
prompt
identif
noroviru
earli
outbreak
posit
impact
inform
appropri
action
prevent
spread
diseas
cepheid
xpert
noroviru
assay
similar
design
genexpert
assay
perform
directli
stool
specimen
distinguish
noroviru
genogroup
ii
studi
sampl
found
compar
cdc
composit
refer
method
xpert
noroviru
assay
demonstr
posit
percent
agreement
genogroup
ii
respect
neg
percent
agreement
genogroup
ii
gonzalez
et
al
prompt
diagnosi
treatment
urinari
tract
infect
uti
sexual
transmit
infect
sti
critic
posit
patient
outcom
complic
delay
treatment
ineffect
treatment
due
misdiagnos
result
increas
risk
acquir
pathogen
hiv
dissemin
exist
infect
circulatori
lymphat
system
develop
pelvic
inflammatori
diseas
lead
infertil
complic
pregnanc
includ
damag
fetu
andor
miscarriag
abil
rapidli
diagnos
infect
particularli
may
asymptomat
still
transmiss
enhanc
diseas
manag
public
health
improv
rate
treatment
time
notif
sexual
partner
followup
test
tradit
diagnost
assay
method
caus
agent
uti
sti
includ
direct
cultur
serolog
immunochromatograph
test
nucleic
acid
amplificationbas
test
dna
amplif
assay
gener
prefer
detect
chlamydia
trachomati
neisseria
gonorrhoea
trichomona
vaginali
papp
et
al
pathogen
lengthi
turnaround
time
specimen
collect
diagnosi
result
delay
administr
appropri
therapi
decreas
efficaci
infect
control
strategi
liu
et
al
khare
et
al
potenti
use
sampletoansw
assay
system
would
sphere
infecti
diseas
manag
narrow
varieti
fdaapprov
clinic
laboratori
improv
amendmentswaiv
test
avail
exampl
approv
sampletoresult
molecular
assay
syphili
new
assay
diagnosi
quantit
hiv
still
develop
stage
fdaapprov
filmarray
panel
uti
sti
pathogen
firstgener
sti
panel
design
detect
identifi
nine
common
sti
pathogen
c
trachomati
n
gonorrhoea
treponema
pallidum
vaginali
mycoplasma
genitalium
haemophilu
ducreyi
herp
simplex
viru
ureaplasma
urealyticum
panel
use
test
clinic
specimen
subject
sti
panel
result
compar
result
standard
clinic
test
perform
duplic
specimen
includ
gram
stain
wet
mount
examin
viral
cultur
serum
syphili
igg
test
concord
filmarray
sti
panel
standard
test
vaginali
c
trachomati
n
gonorrhoea
assay
also
detect
pallidum
sampl
four
patient
subsequ
diagnos
syphili
serolog
cepheid
xpert
ctng
assay
detect
c
trachomati
n
gonorrhoea
vagin
swab
endocerv
swab
male
femal
urin
sensit
specif
target
found
exceed
respect
causer
et
al
illustr
potenti
impact
rapid
diagnost
sampletoansw
platform
public
health
pointofcar
context
asymptomat
men
test
onsit
sexual
health
clinic
use
xpert
ctng
assay
rapid
turnaround
time
assay
enabl
infect
patient
test
receiv
appropri
treatment
day
test
contrast
turnaround
time
specimen
test
offsit
laboratori
use
convent
method
day
gaydo
one
area
potenti
improv
exist
assay
lack
valid
studi
support
test
rectal
pharyng
specimen
would
use
mani
gonococc
chlamydi
infect
rectal
oropharyng
tissu
asymptomat
test
rectal
swab
show
sensit
specif
xpert
ctng
assay
c
trachomati
n
gonorrhoea
respect
goldenberg
et
al
infect
herp
simplex
viru
hsv
common
caus
genit
oral
sti
initi
acut
phase
infect
virus
typic
enter
latent
phase
rate
subclin
hsv
shed
tend
decreas
first
year
infect
follow
initi
clinic
episod
viral
shed
may
persist
high
rate
infect
individu
sever
year
infect
phipp
et
al
addit
hsv
reactiv
latenc
primari
infect
caus
clinic
recurr
local
diseas
accompani
high
rate
viral
shed
continu
risk
pose
hsv
horizont
transmiss
sexual
partner
vertic
transmiss
mother
infant
make
diagnosi
patient
may
activ
shed
import
diseas
manag
simplexa
hsv
direct
kit
approv
genit
swab
sampl
accord
manufactur
sensit
specif
assay
genit
swab
hsv
hsv
exce
focu
diagnostic
infect
central
nervou
system
cn
notabl
divers
uniqu
challeng
present
due
potenti
morbid
mortal
caus
conjunct
inher
difficulti
involv
diagnosi
treatment
patient
cn
infect
may
display
depress
level
conscious
photophobia
alter
mental
state
fever
lethargi
wide
rang
symptomolog
etiolog
agent
cn
infect
may
rang
virus
bacteria
fungi
even
parasit
infect
often
produc
chang
cerebrospin
fluid
csf
make
valuabl
specimen
diagnost
analys
viral
infect
common
form
asept
mening
enterovirus
common
viral
caus
particularli
pediatr
case
hong
et
al
diseas
gener
selflimit
typic
treat
support
therapi
difficult
base
symptomolog
differenti
earli
stage
bacteri
mening
far
seriou
diseas
lead
death
within
hour
leav
patient
perman
brain
damag
hear
loss
learn
disabl
potenti
serious
cn
infect
unusu
patient
admit
treat
broadspectrum
antibiot
clear
diagnosi
made
therefor
would
reason
postul
rapid
accur
diagnosi
enteroviralassoci
mening
infect
would
help
prevent
unnecessari
use
antibiot
shorten
durat
hospit
reduc
healthcar
cost
ramer
et
al
king
et
al
repres
ideal
context
accur
fast
sampletoansw
assay
system
filmarray
meningitisenceph
panel
fda
approv
panel
target
pathogen
detect
e
coli
haemophilu
influenza
listeria
monocytogen
neisseria
meningitidi
streptococcu
agalactia
streptococcu
pneumonia
cytomegaloviru
enteroviru
human
parechoviru
varicella
zoster
viru
cryptococcu
neoforman
preclin
assess
panel
use
csf
specimen
report
posit
neg
agreement
across
method
respect
result
obtain
meningitisenceph
panel
compar
result
routin
test
method
discrep
resolv
use
addit
nucleic
acid
amplif
test
direct
sequenc
hanson
et
al
second
studi
use
panel
hivinfect
popul
uganda
detect
cryptococcu
csf
patient
diagnos
first
episod
cryptococc
mening
fungal
cultur
sensit
specif
rhein
et
al
cepheid
xpert
ev
assay
also
test
presenc
enteroviru
rna
csf
manufactur
report
specif
sensit
assay
exceed
respect
independ
set
studi
compar
patient
asept
mening
diagnos
use
xpert
ev
assay
patient
diagnos
basi
convent
inhous
pcr
assay
patient
diagnos
patient
diagnosi
confirm
xpert
ev
significantli
shorter
durat
broadspectrum
antibiot
administr
fewer
patient
receiv
acyclovir
averag
length
stay
patient
day
compar
day
day
patient
group
convent
pcr
diagnosi
respect
report
sensit
assay
specif
giulieri
et
al
marlow
et
al
kost
et
al
addit
diseasecaus
potenti
sti
also
caus
enceph
common
pediatr
case
immedi
treatment
antivir
drug
acyclovir
indic
patient
suspect
base
symptomolog
hsvassoci
enceph
left
untreat
mortal
rate
patient
approach
raschila
et
al
iron
administr
power
antivir
drug
patient
may
actual
interfer
tradit
diagnosi
viral
cultur
result
fals
neg
result
advers
effect
impact
pcrbase
assay
make
detect
hsv
use
either
filmarray
meningitisenceph
panel
simplexa
hsv
direct
kit
approv
use
csf
specimen
faster
reliabl
diagnost
option
around
world
rapid
growth
demand
law
enforc
agenc
human
dna
ident
test
ie
dna
profil
connect
crimin
investig
driven
develop
expedi
techniqu
handl
increas
number
sampl
submit
analysi
multiarray
capillari
electrophoret
instrument
allow
simultan
analysi
multipl
sampl
well
direct
pcr
amplif
methodolog
elimin
need
extract
quantif
acceler
individu
step
dna
analysi
process
still
accur
human
dna
profil
trace
otherwis
challeng
sampl
still
requir
substanti
handson
time
train
forens
analyst
central
laboratori
segment
workflow
use
extract
dna
amplifi
target
genet
marker
fraction
amplicon
interpret
data
produc
meaning
dna
profil
full
integr
step
dna
process
workflow
compact
system
term
rapid
dna
autom
rapid
dna
system
allow
gener
full
str
dna
profil
fraction
time
requir
convent
laboratori
method
minim
user
intervent
provid
forens
investig
law
enforc
abil
identifi
possibl
perpetr
quickli
repres
advantag
tri
obtain
warrant
apprehend
suspect
asid
assist
law
enforc
militari
intellig
gener
investig
lead
rapid
dna
system
also
provid
forens
laboratori
faster
sampl
process
time
analysi
refer
sampl
full
potenti
valu
sampletoprofil
system
becam
evid
us
suprem
court
decis
maryland
v
king
court
rule
collect
analysi
buccal
swab
arreste
dna
profil
purpos
legitim
polic
book
procedur
moreov
court
rule
arreste
dna
profil
could
use
law
enforc
search
crimin
dna
databas
part
determin
whether
releas
individu
arrest
decis
made
instantli
obviou
need
valu
abl
gener
dna
profil
arreste
polic
book
station
rather
offsit
forens
laboratori
first
fulli
integr
rapid
dna
system
human
identif
rapidhit
human
dna
identif
system
integenx
use
globalfil
express
assay
system
produc
dna
profil
consist
autosom
sexdetermin
marker
buccal
swab
sampl
type
less
h
regardless
speed
integr
system
would
use
forens
purpos
meet
accept
sensit
precis
accuraci
standard
use
refer
qualiti
buccal
swab
platform
success
rate
produc
complet
profil
jovanovich
et
al
dilut
seri
dna
place
onto
swab
introduc
platform
full
profil
obtain
ng
dna
partial
profil
obtain
littl
ng
input
dna
buccal
swab
analyz
rapidhit
system
found
concord
profil
gener
tradit
laboratori
method
result
allel
size
within
bp
correspond
allel
allel
ladder
demonstr
accept
precis
hennessi
et
al
data
support
use
rapidhit
system
analysi
singlesourc
buccal
sampl
expedi
profil
referencequ
sampl
asid
aid
forens
laboratori
process
refer
sampl
quickli
multipl
applic
rapid
dna
test
refer
sampl
feder
immigr
offici
investig
use
technolog
analysi
refer
type
sampl
verifi
children
enter
unit
state
relat
accompani
adult
depart
homeland
secur
would
like
employ
rapid
dna
test
support
reject
claim
famili
related
use
justifi
permiss
immigr
border
port
technolog
could
help
ensur
individu
enter
counti
terrorist
dna
databas
anoth
rapid
dna
system
dnascan
healthcar
netbio
first
rapid
dna
system
approv
upload
gener
refer
dna
profil
nation
dna
index
system
fbi
clearli
demonstr
system
abil
gener
action
intellig
law
enforc
unit
state
polic
agenc
arizona
florida
south
carolina
name
also
begun
use
platform
gener
investig
lead
casework
sampl
rate
dna
profil
success
casework
sampl
appear
sampledepend
full
profil
gener
cigarett
butt
rang
success
n
sampl
donor
drink
item
rang
success
n
sampl
donor
chew
gum
rang
success
n
sampl
donor
verheij
et
al
given
high
variabl
success
rate
profil
detect
forens
type
sampl
addit
improv
sensit
system
need
allow
applic
analysi
challeng
sampl
type
touch
contact
dna
sampl
typic
trace
quantiti
dna
dna
quantiti
limit
touch
type
sampl
demonstr
possibl
produc
full
dna
profil
use
tradit
laboratori
methodolog
follow
reextract
sampl
previous
analyz
rapidhit
system
indic
rapidhit
system
consum
avail
biolog
materi
thong
et
al
verheij
et
al
import
consid
limit
natur
mani
forens
type
sampl
sinc
demonstr
effici
dna
extract
achiev
success
rate
casework
sampl
might
improv
polic
interest
analysi
casework
sampl
sampletoprofil
integr
system
order
determin
prior
suspect
releas
whether
individu
potenti
connect
item
evid
crime
scene
militari
applic
casework
sampl
includ
analys
munit
weapon
determin
attribut
current
howev
fbi
polici
requir
casework
sampl
undergo
humanspecif
quantif
step
step
part
integr
workflow
sampletoprofil
system
casework
sampl
analyz
use
rapid
dna
system
must
still
reanalyz
follow
tradit
laboratori
workflow
exemplifi
advanc
technolog
push
ahead
exist
polici
widespread
use
sampletoprofil
system
casework
sampl
therefor
necessit
chang
offici
polici
take
account
technic
capabl
new
platform
altern
quantif
modul
would
need
ad
rapid
dna
system
even
though
necessari
accur
reliabl
oper
instrument
develop
pcr
technolog
initi
transform
chang
field
molecular
biolog
rapid
growth
big
data
analyt
human
genom
major
drive
forc
behind
similar
transform
chang
medic
diagnost
health
care
meant
diagnost
treatment
option
tailor
physiolog
averag
patient
physician
healthcar
profession
speak
promis
precis
medicin
person
patient
uniqu
physiolog
genet
background
import
part
make
person
care
realiti
abil
obtain
patient
test
data
manner
timeli
possibl
use
tradit
laborintens
assay
method
one
import
goal
molecular
diagnost
therefor
alway
develop
faster
costeffect
approach
perform
diagnost
assay
initi
took
form
emphasi
largescal
autom
highthroughput
instrument
central
laboratori
use
onesizefitsal
segment
workflow
bring
analys
closer
patient
form
pointofcar
diagnost
hope
sever
process
step
could
elimin
therebi
facilit
shorter
time
result
faster
health
manag
respons
better
therapeut
turnaround
time
ultim
greater
opportun
improv
patient
outcom
make
goal
realiti
howev
achiev
reli
largescal
autom
rather
process
integr
miniatur
driven
larg
advanc
engin
guid
diagnost
need
physician
patient
specif
advanc
microfluid
microscal
autom
made
possibl
fulli
integr
handheld
scale
previous
segment
process
nucleic
acid
extract
purif
pcr
amplif
amplicon
detect
even
complex
task
electrophoret
size
fraction
miniatur
also
came
abil
reduc
process
time
produc
answer
quickli
simpl
reliabl
user
friendli
fulli
integr
diagnost
system
term
sampletoansw
sampletoprofil
test
enter
common
lexicon
molecular
diagnost
forensichuman
ident
test
commun
econom
forc
diagnost
industri
motiv
wellestablish
player
like
ge
host
new
market
entrant
develop
make
commerci
avail
rapidli
expand
select
diagnost
dna
profil
tool
major
area
focu
commerci
system
assay
infecti
diseas
diagnost
given
industri
still
infanc
howev
still
enorm
room
growth
technolog
improv
menu
avail
assay
expand
new
pathogen
panel
drug
resist
panel
assay
genet
marker
human
diseas
predisposit
cepheid
alreadi
move
direct
xpert
fii
fv
assay
human
gene
variant
associ
thrombophilia
cours
infecti
pathogen
mutat
need
modifi
assay
exist
assay
improv
use
patient
sampl
type
engin
side
continu
advanc
materi
scienc
fabric
technolog
drive
develop
true
pointofcar
diagnost
instrument
smaller
faster
portabl
enough
use
patient
bedsid
industri
well
posit
bright
futur
one
potenti
obstacl
need
address
regard
sampletoansw
devic
cost
much
instrument
base
unit
rather
cost
per
assay
case
appreci
higher
price
tradit
assay
method
cours
argu
new
technolog
cost
invari
drop
technolog
matur
moreov
sinc
mani
assay
target
multipl
pathogen
singl
assay
run
cost
per
pathogen
target
provid
user
better
overal
valu
seri
test
perform
la
cart
basi
also
may
worth
ask
abil
easi
test
wide
rang
pathogen
simpl
test
produc
shift
physician
think
patient
diagnost
multiplex
panel
reduc
amount
time
physician
would
normal
spend
tri
narrow
preliminari
diagnosi
like
caus
agent
test
routin
test
pathogen
might
rise
top
physician
list
like
suspect
provid
new
insight
complex
diseas
process
ensur
respons
care
patient
whose
condit
fall
within
probabl
etiolog
import
valid
studi
demonstr
reliabl
precis
accuraci
sampletoansw
assay
overst
need
go
handinhand
rigor
assess
impact
system
patient
care
necessari
suffici
assay
fit
purpos
ultim
longterm
success
amaz
system
rest
abil
show
clear
valu
sampletoprofil
system
use
human
ident
test
valu
might
quantifi
term
crime
prevent
solv
medic
diagnost
assay
necessari
demonstr
use
result
shorter
hospit
stay
elimin
unnecessari
ineffectu
treatment
improv
patient
outcom
overal
quantifi
reduct
healthcar
cost
